These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24117612)

  • 1. Upregulation of membrane-bound CD40L on CD4+ T cells in women with primary Sjögren's syndrome.
    Belkhir R; Gestermann N; Koutero M; Seror R; Tost J; Mariette X; Miceli-Richard C
    Scand J Immunol; 2014 Jan; 79(1):37-42. PubMed ID: 24117612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome.
    Gestermann N; Koutero M; Belkhir R; Tost J; Mariette X; Miceli-Richard C
    Eur Cytokine Netw; 2012; 23(4):166-72. PubMed ID: 23302156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40L demethylation in CD4(+) T cells from women with rheumatoid arthritis.
    Liao J; Liang G; Xie S; Zhao H; Zuo X; Li F; Chen J; Zhao M; Chan TM; Lu Q
    Clin Immunol; 2012 Oct; 145(1):13-8. PubMed ID: 22889643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome.
    Miceli-Richard C; Wang-Renault SF; Boudaoud S; Busato F; Lallemand C; Bethune K; Belkhir R; Nocturne G; Mariette X; Tost J
    Ann Rheum Dis; 2016 May; 75(5):933-40. PubMed ID: 26183421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility.
    Lian X; Xiao R; Hu X; Kanekura T; Jiang H; Li Y; Wang Y; Yang Y; Zhao M; Lu Q
    Arthritis Rheum; 2012 Jul; 64(7):2338-45. PubMed ID: 22231486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced CD40L expression on ex vivo activated CD4+ T-lymphocytes from patients with excellent renal allograft function measured with a rapid whole blood flow cytometry procedure.
    Lederer SR; Friedrich N; Gruber R; Landgraf R; Toepfer M; Sitter T
    Int Arch Allergy Immunol; 2004 Mar; 133(3):276-84. PubMed ID: 14976397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective DNA methylation in salivary gland epithelial acini from patients with Sjögren's syndrome is associated with SSB gene expression, anti-SSB/LA detection, and lymphocyte infiltration.
    Konsta OD; Le Dantec C; Charras A; Cornec D; Kapsogeorgou EK; Tzioufas AG; Pers JO; Renaudineau Y
    J Autoimmun; 2016 Apr; 68():30-8. PubMed ID: 26725749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.
    Thabet Y; Le Dantec C; Ghedira I; Devauchelle V; Cornec D; Pers JO; Renaudineau Y
    J Autoimmun; 2013 Mar; 41():175-81. PubMed ID: 23478041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome.
    Yin H; Zhao M; Wu X; Gao F; Luo Y; Ma L; Liu S; Zhang G; Chen J; Li F; Zuo X; Lu Q
    J Dermatol Sci; 2010 Sep; 59(3):198-203. PubMed ID: 20724115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E4BP4 overexpression: a protective mechanism in CD4+ T cells from SLE patients.
    Zhao M; Liu Q; Liang G; Wang L; Luo S; Tang Q; Zhao H; Su Y; Yung S; Chan TM; Lu Q
    J Autoimmun; 2013 Mar; 41():152-60. PubMed ID: 23340290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased interleukin (IL)-7Rα expression in salivary glands of patients with primary Sjogren's syndrome is restricted to T cells and correlates with IL-7 expression, lymphocyte numbers and activity.
    Bikker A; Kruize AA; Wenting M; Versnel MA; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Jun; 71(6):1027-33. PubMed ID: 22312161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.
    Sellam J; Miceli-Richard C; Gottenberg JE; Ittah M; Lavie F; Lacabaratz C; Gestermann N; Proust A; Lambotte O; Mariette X
    Ann Rheum Dis; 2007 Jun; 66(6):790-7. PubMed ID: 17185325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
    Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
    J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of increased susceptibility to apoptosis of CD4+ T cells with lymphocyte activation and activity of disease in patients with primary Sjögren's syndrome.
    Zeher M; Szodoray P; Gyimesi E; Szondy Z
    Arthritis Rheum; 1999 Aug; 42(8):1673-81. PubMed ID: 10446867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
    Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of leflunomide in primary Sjogren's syndrome is associated with regulation of T-cell activity and upregulation of IL-7 receptor α expression.
    Bikker A; van Woerkom JM; Kruize AA; van der Wurff-Jacobs KM; Bijlsma JW; Lafeber FP; van Roon JA
    Ann Rheum Dis; 2012 Dec; 71(12):1934-41. PubMed ID: 22563027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor and nerve growth factor correlate with T-cell activation in primary Sjogren's syndrome.
    Fauchais AL; Boumediene A; Lalloue F; Gondran G; Loustaud-Ratti V; Vidal E; Jauberteau MO
    Scand J Rheumatol; 2009; 38(1):50-7. PubMed ID: 18830907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome.
    Lavie F; Miceli-Richard C; Quillard J; Roux S; Leclerc P; Mariette X
    J Pathol; 2004 Apr; 202(4):496-502. PubMed ID: 15095277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a new regulatory CD4+ T cell subset in primary Sjögren's syndrome.
    Alunno A; Petrillo MG; Nocentini G; Bistoni O; Bartoloni E; Caterbi S; Bianchini R; Baldini C; Nicoletti I; Riccardi C; Gerli R
    Rheumatology (Oxford); 2013 Aug; 52(8):1387-96. PubMed ID: 23674818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
    Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
    Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.